Effects of Task-oriented Training on Functional Mobility & Fatigue in

Status Not yet recruiting

Clinical Trial Summary

Multiple Sclerosis (MS) is inflammatory, demyelinating and autoimmune disease of the central nervous system. It is usually seen with relapses and genetic and environmental factors play a role in the etiology. Neurological symptoms seen in MS restrict the patient's daily activity and social role participation. Mobility problems and fatigue are the most important reasons of role limitations and decreased quality of life. The importance of exercise training in disease management has been emphasized in recent years. However, few studies have investigated the effects of task-oriented trainings on symptoms of the disease. The aim of this sudy is to investigate the effects of task-oriented training additional to combined exercise training on functional capacity, mobility, balance, fatigue and quality of life in patients with MS.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03497468
Study type	Interventional
Source	Bezmialem Vakif University
Contact	Kamer Unal-Eren, PT, PhD
Phone	+902125232288
Email	kamerunals@yahoo.com
Status	Not yet recruiting
Phase	N/A
Start date	April 2018
Completion date	June 2018

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT02861014` - A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)	Phase 3
Terminated	`NCT01435993` - Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis	Phase 1
Completed	`NCT02410200` - Study of the Effect of BG00012 on MRI Lesions and Pharmacokinetics in Pediatric Subjects With RRMS	Phase 2
Completed	`NCT01116427` - A Cooperative Clinical Study of Abatacept in Multiple Sclerosis	Phase 2
Completed	`NCT01108887` - An Observational Study for the Assessment of Adherence, Effectiveness and Convenience of Rebif® Treatment in Relapsing Multiple Sclerosis Patients Using RebiSmart™.	N/A
Completed	`NCT01141751` - An Observational Study Comparing Multiple Sclerosis International Quality of Life Questionnaire (MusiQoL) and Multiple Sclerosis Quality of Life-54 Instrument (MSQOL-54) in Relapsing Multiple Sclerosis (RMS) Patients on Long-term Rebif® Therapy	N/A
Completed	`NCT00097331` - Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis	Phase 2
Completed	`NCT00071838` - Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis	Phase 2
Active, not recruiting	`NCT02545868` - A Study to Evaluate the Effects of Ocrelizumab on Immune Responses In Participants With Relapsing Forms of Multiple Sclerosis	Phase 3
Completed	`NCT02687919` - Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis	N/A
Recruiting	`NCT01453868` - The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis	Phase 0
Completed	`NCT01279876` - Melatonin in Relapsing-Remitting Multiple Sclerosis Patients	Phase 2
Completed	`NCT02275741` - Study to Investigate the Immune Response and Safety of Prophylactic Vaccines in Patients Treated for Multiple Sclerosis	N/A
Terminated	`NCT00780455` - Rehabilitation Study in MS Patients	Phase 4
Completed	`NCT00548405` - Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two	Phase 3
Completed	`NCT00242177` - Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability	Phase 1
Recruiting	`NCT03205280` - Clinical Decision Support System (CADIMS) for MS Diagnostic
Completed	`NCT01431937` - Assessment of Repeat Ascending Doses of GSK2018682 in Healthy Volunteers	Phase 1
Recruiting	`NCT03342638` - Maximizing Outcome of Multiple Sclerosis Transplantation	Phase 3
Not yet recruiting	`NCT03283397` - A Phase IIIb, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Patients With RRMS	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effects of Task-oriented Training on Functional Mobility and Fatigue in Patients With Multiple Sclerosis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms